Crossmark

Preclinical evaluation of a 64Cu-labeled αvβ6-targeting peptide PET probe for pancreatic cancer: from radiometal production to molecular probe validation

Crossref DOI link: https://doi.org/10.1007/s10967-026-10747-w

Published Online: 2026-02-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pang, Xiao

Zhao, Liujing

Yu, Yanqin

Zhan, Yousheng

Zhou, Yuchuan

Ma, Daiyuan

Li, Suping https://orcid.org/0000-0002-9702-4265
Funding

Funding for this research was provided by:

Natural Science Foundation of Sichuan Province (2024NSFSC0668)

Institutional Research Development Fund Project of North Sichuan Medical College (CBY23-QNA39)
License Information

Text and Data Mining valid from 2026-02-05

Version of Record valid from 2026-02-05
More Information

Article History

Received: 25 June 2025

Accepted: 16 January 2026

First Online: 5 February 2026

Declarations

:

: The authors declare no conflicts of interest. The authors utilized an AI tool (Deepseek, China) for language polishing and grammar checking during the preparation of this manuscript.

: The animal study protocol was approved by the guidelines of the Animal Ethics Committee of North Sichuan Medical College (No. 2021116).

Document is current

Any future updates will be listed below